Home

Letters, Testimony & Comments

Testimony in Support of Economic Development and Jobs for the Michigan Bioscience Industry
September 13, 2011
Economic Development and Jobs for the Michigan Bioscience Industry Michigan House and Senate Standings Committee on the Biosciences...
September 13 2011
Biotech Leader Provides Testimony at Congressional Hearing on SBIR/STTR Renewal
April 7, 2011
Hearing Testimony Scott Koenig, M.D., PH.D. Before the House of Representatives Committee on Small Business Good morning Chairman...
April 7 2011
The American Research and Competitiveness Act: BIO supports the Research and Development Tax Credit
March 24, 2011
On behalf of the Biotechnology Industry Organization (BIO) and its more than 1,100 member companies, academic institutions, state...
March 24 2011
Comments, National Trade Estimate (NTE) Report on Foreign Trade Barriers and Reports on Sanitary and Phytosanitary and Standards-Related Foreign Trade Barriers
November 1, 2009
  Dear Ms. Blue: The Biotechnology Industry Organization (BIO) is submitting this letter in response to the request by the...
November 1 2009
Consolidation of Variable Interest Entities: FASB issues amendments to FIN46(R)
November 15, 2008
BIO urges that changes to FIN46(R) accurately reflect the underlying economics of collaborations.
November 15 2008
SBIR: Letter from Patient Groups
September 18, 2008
The letter, signed by approximately 60 patient groups, emphasizes support for restoring eligibility in the SBIR program to venture-backed...
September 18 2008
Accounting for Convertible Debt: FASB issues Staff Position on accounting changes for convertible debt instruments
October 27, 2007
BIO addresses concerns to FASB’s Staff Position on accounting for instrument C and conventional convertible debt.
October 27 2007
SBIR: Letter from Biotech CEOs
July 26, 2005
The letter, signed by over 280 biotech executives, emphasizes support for restoring eligibility in the SBIR program to venture-backed...
July 26 2005
Letter from Sens. Specter and Santorum and members of the House PA delegation
March 25, 2004
March 25 2004
Letter from 30 Congressmembers urging Chairman Manzullo and Chairwoman Snowe to include a correction in SBA Reauthorization legislation (S. 1375/HR 2802)
December 10, 2003
December 10 2003
Letter from Sens. Olympia J. Snowe, Christopher S. Bond, Robert F. Bennett
November 4, 2003
To Hector Barreto, Administrator, U.S. Small Business Administration
November 4 2003
Letter from Sen. Edward Kennedy
October 21, 2003
To Hector Barreto, Administrator, U.S. Small Business Administration
October 21 2003
Letter to Mr. Gary Jackson, Asst. Administrator for Size Standards, U.S. Small Business Administration
July 7, 2003
July 7 2003
Letter to Hector Barreto
May 13, 2003
Administrator, U.S. Small Business Administration
May 13 2003
Small Business Early Stage Investment Program: Legislative Text
Part D-Small Business Early-Stage Investment Program Sec. 399A Establishment of Program The Administrator shall establish and carry...

Letters, Testimony & Comments

Testimony in Support of Economic Development and Jobs for the Michigan Bioscience Industry
September 13 2011
Economic Development and Jobs for the Michigan Bioscience Industry Michigan House and Senate Standings Committee on the Biosciences...
Biotech Leader Provides Testimony at Congressional Hearing on SBIR/STTR Renewal
April 7 2011
Hearing Testimony Scott Koenig, M.D., PH.D. Before the House of Representatives Committee on Small Business Good morning Chairman...
The American Research and Competitiveness Act: BIO supports the Research and Development Tax Credit
March 24 2011
On behalf of the Biotechnology Industry Organization (BIO) and its more than 1,100 member companies, academic institutions, state...
Comments, National Trade Estimate (NTE) Report on Foreign Trade Barriers and Reports on Sanitary and Phytosanitary and Standards-Related Foreign Trade Barriers
November 1 2009
  Dear Ms. Blue: The Biotechnology Industry Organization (BIO) is submitting this letter in response to the request by the...
Consolidation of Variable Interest Entities: FASB issues amendments to FIN46(R)
November 15 2008
BIO urges that changes to FIN46(R) accurately reflect the underlying economics of collaborations.
More Letters, Testimony & Comments →

Press Releases

Ken Lisaius Named BIO's Vice President of Communications
January 23 2013
Washington, D.C. (January 23, 2013) –  The Biotechnology Industry Organization (BIO) announced that Ken...
TREAT Act Offers Renewed Hope for Patients
February 15 2012
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay...
BIO Applauds Congress for Reauthorizing SBIR/STTR Programs
December 16 2011
Washington, DC (December 16, 2011) – The Biotechnology Industry Organization (BIO) praises the House and Senate...
BIO Applauds House and Senate for Reaching Deal on SBIR Reauthorization
December 13 2011
Washington, DC (December 13, 2011) – The Biotechnology Industry Organization (BIO) today praises the House and...
BIO Announces Presenting Companies for 14th Annual BIO CEO & Investor Conference
November 22 2011
WASHINGTON, D.C. (November 22, 2011) - The Biotechnology Industry Organization (BIO) today announced the initial...
More Press Releases →